Publisher agreements

For the years 2023 and 2024, a consortial publish-and-read agreement has been reached with the publisher BMJ. This gives Charité scientists several advantages. You have read-only access to the publisher's journals and can publish open access in selected hybrid journals.

You are eligible for publishing if:

• the corresponding author is a member of the Charité,
• the acceptance date of your publication is in 2023 or 2024,
• your article corresponds to the article type "Research" and
• the journal is one of the 26 journals participating [PDF] in the agreement.

If you have any questions, please feel free to contact us:

Open Access

Members of the Charité - Universitätsmedizin Berlin have reading access to Cambridge University journals in the period 2019 - 2024 and can publish open access in selected journals. This option is made possible by the Charité Medical Library's participation in a consortial publish-and-read agreement.

When you submit your manuscript using your Charité email address, you should automatically be recognized as eligible to publish open access under this agreement.

Under the 2022-2024 agreement you can publish open access if the following criteria also apply:

• You are corresponding author
• the acceptance date of your article falls within the agreement period
• your article is a Research Article, Review Article, Rapid Communication, Brief Communication or Case Report
• The journal is hybrid or gold

Please note that color charges are not covered by the agreement and cannot be refunded.

More information about the agreement can be found on the publisher's website.

A consortial publish-and-read agreement has been made with the publisher Hogrefe for 2021 - 2023. This gives Charité researchers several advantages. They have access to the publisher's journals and can publish Open Access (OA) in selected journals.

If you:

• are a corresponding author with a primary affiliation to Charité
• publish open access in one of the 29 participating journals, and
• are publishing an article type classified as an original work or subcategory thereof,

you will automatically be recognised by the publisher as eligible for open access publication. The costs are (as yet) covered by the Medical Library's subscriptions to the publisher Hogrefe.
Further information on the agreement as well as a list of participating journals can be found on the Hogrefe-website. 
If you have any questions about the procedure, please contact the publisher directly.

Due to the participation of the Medical Library of the Charité in a national consortium agreement (duration 2022-24), where the Article Processing Charges have already been paid, the following possibilities for Open Access publication (under the standard license CC BY 4.0) exist for Charité corresponding authors:

• in hybrid journals (title list (A + B only))
• in gold open access journals (title list (D only)).

The agreement applies to all "Primary Research" articles accepted in the above period, including "research papers", "special issue articles", "letters" and "review articles".

The Charité Medical Library has an agreement with MDPI with an end date of 31.03.24. The agreement provides 10% discount on publication fees.

The publication process for authors:

You are a "corresponding author" and submit your manuscript directly to the journal as usual. Please indicate your affiliation with Charité - Universitätsmedizin Berlin upon submission (in the drop-down menu). The publisher will then send you an invoice so that you can make payment.

If you are planning to apply for financial support from the Publication Fund, then please use our online application form (DE).

An agreement has been concluded with the publisher Portland Press for the years 2022 - 2024. Members of Charité - Universitätsmedizin Berlin have reading access to the publisher's journals and can publish open access (OA) in all seven journals. This option is made possible for Charité members through the Medical Library's participation in a cross-regional consortium agreement for an e-journal package, for which OA rights have been negotiated.

You can publish open access free of charge in the following journals:

• Biochemical Journal
• Biochemical Society Transactions
• Clinical Science
• Essays in Biochemistry
• Emerging Topics in Life Sciences
• Neuronal Signaling
• Bioscience Reports

For questions concerning the workflow, please contact the publisher directly.

This hybrid journal does not qualify for financial support through the Publication Fund.

Due to the participation of the Charité Medical Library in a national consortium agreement, a discount of $500 is granted for the Immediate OA option ($4,975 instead of $5,475 for research articles up to 12 pages). Immediate OA is published under a CC BY license as standard.

If you have any questions about the discount, please contact the publisher directly.
 

For the years 2021 - 2023, a consortial publish-and-read agreement has been concluded with the publisher Sage. This gives Charité scholars several advantages. You have read-only access to the publisher's journals and can publish Open Access (OA) in selected journals.

OA in hybrid journals

OA costs are covered by the agreement when Charité corresponding authors publish in „SAGE Choice“ journals and the manuscript is assigned to one of the following article types: Original Research Paper, Review Paper, Brief Communication, Short Reports, or Case Report.

OA Gold Journals

Similarly, Charité corresponding authors receive a 20% discount on publication costs when publishing in a Sage Gold Open Access Journal.

The agreement does not include cost coverage for articles in gold journals. You can still apply to the publication fund if your article meets all funding conditions.

The Charité - Universitätsmedizin Berlin is a participant in the DEAL contract with Springer Nature.

The complete and continuously updated list of Springer Nature journals [xlsx] that are part of the DEAL contract can be downloaded as an Excel file from the MPDL via Keeper.

Gold OA: Articles in journals that are 100% OA.

Springer Nature Gold OA journals are marked as "Fully Open Access" in the list of participating Springer Nature journals linked above.

For the funding year 2022 applies:

Articles that have been accepted in 2022 and notified to the library by the publisher are eligible for funding. The specific funding amount depends on the fee or Article Processing Charge (APC) due for your OA article.

Articles with an APC of up to 1,680 EUR net (2,000 EUR gross) are fully funded. If the amount due is above this price limit, the costs are split: 50% of the costs are covered by the Medical Library, up to a maximum of 2,000 EUR. The remaining costs must be financed via the corresponding author’s Charité cost code (“Kostenstelle” or “Innenauftragsnummer”).

This means that if the total costs exceed 4,000 EUR gross, then the amount to be provided by you as the author will be higher than 50% of the invoiced APC.

As of 01.01.2023, DEAL Gold articles will be funded according to the current eligibility criteria of the Publication Fund. Please refer to our "Publication fund" website for more information.

Once the library is notified by the publisher and approved your article under the DEAL contract, you will receive an e-mail from the Open Access Team of the Medical Library. In the case of shared or no funding, you will be informed of the article gross fee and the amount of library funding, and asked to provide a Charité cost code (“Kostenstelle” or “Innenauftragsnummer”) so that your own share of the publication costs can be booked. The calculation of the article gross fee is based on the list of Springer Nature journals [xlsx]: worksheet „included“ column J "Current DEAL Cost Contribution (until end of 2023)”, plus 19% VAT for articles accepted until 31.12.2023.

Articles in hybrid journals

Springer Nature hybrid journals are marked as "Hybrid (Open Choice)" in the list of participating Springer Nature journals linked above. During the ongoing transformative agreements with Springer Nature, the costs for OA articles published in hybrid journals by Charité members (corresponding authors) are still covered by the subscription feespaid by Charité. This means that you as authors do not currently need to pay any additional article fees.

Further information

The (partial) funding of DEAL articles is provided by the Medical Library if the following criteria are met:

• "Corresponding Author" is a member of the Charité.
• The journal appears on the above linked list of Springer Nature journals that are part of the DEAL agreement.
• Acceptance date within the term of the DEAL agreement (until end 2023)
• The following contribution types are supported by the DEAL contract. This varies depending on the type of journal:
• Hybrid Journals: Research Articles (= Original Paper, Review Paper, Brief Communication) and Non-Research Articles (= Editorial Notes, Book Reviews, Letters, Reports (except: Non-Research Articles in specialist journals).
• Gold OA journals: Research Articles (= Original Paper, Review Paper, Brief Communication). All other article types are excluded.
• From 01.01.2023, the eligibility criteria of the Publication Fund will also apply to all articles from 100% Open Access journals (Gold OA) and eligible journals will appear on the list of Eligible Journals

Further information from the publisher can be found at  springernature.com.

If you have any questions about the process, please contact us.

Open Access 

The Charité - Universitätsmedizin Berlin is a participant in the DEAL agreement with the publisher Wiley.

This brings Charité scientists several advantages. They have read access to almost all journals published by Wiley and can publish Open Access in eligible Wiley journals [.xlsx file] as corresponding author. This does not apply to titles that were published by Hindawi until the end of 2020 and are now published by Wiley from 2021 onwards.

Articles in journals that are 100% OA (Gold OA)

For the funding year 2022 applies:

Articles that have been accepted in 2022 and notified to the library by the publisher are eligible for funding. The specific funding amount depends on the fee or Article Processing Charge (APC) due for your OA article.

Articles with an APC of up to 1,680 EUR net (2,000 EUR gross) are fully funded. If the amount due is above this price limit, the costs are split: 50% of the costs are covered by the Medical Library, up to a maximum of 2,000 EUR. The remaining costs must be financed via the corresponding author’s Charité cost code (“Kostenstelle” or “Innenauftragsnummer”).

This means that if the total costs exceed 4,000 EUR gross, then the amount to be provided by you as the author will be higher than 50% of the invoiced APC.

As of 01.01.2023, DEAL Gold articles will be funded according to the current eligibility criteria of the Publication Fund. Please refer to our "Publication fund" website for more information.

If your article is fully or partially funded, you will receive an e-mail from the Open Access Team of the Medical Library. In the case of shared funding,

Once the library is notified by the publisher and approved your article under the DEAL contract, you will receive an e-mail from the Open Access Team of the Medical Library. In the case of shared or no funding, you will be informed of the article gross fee and the amount of library funding, and asked to provide a Charité cost code (“Kostenstelle” or “Innenauftragsnummer”) so that your own share of the publication costs can be booked.

The calculation of the article gross fee is based on the Wiley journal lists (column L "EUR APC" minus 20% DEAL discount plus 19% VAT applies).

Articles in hybrid journals

During the ongoing transformative agreements with Wiley, the costs for OA articles published in hybrid journals by Charité members (corresponding authors) are still covered by the subscription fees paid by Charité. This means that you as authors do not currently need to pay any additional article fees.

Further information

The (proportional) funding of DEAL articles is provided by the Medical Library if the following criteria are met:

• "Corresponding Author" is a member of the Charité.
• Acceptance date within the term of the DEAL agreement (until end 2022)
• Article type: "primary research" or "review article
• From 01.01.2023, the eligibility criteria of the Publication Fund will also apply to all articles from 100% Open Access journals (Gold OA) and eligible journals will appear on the list of Eligible Journals.

The publication process for authors:

• The publication process differs depending on whether you submit your manuscript to a pure OA journal or to a hybrid journal.
• In the case of a gold OA journal, you already select Charité as your institution when submitting. Charité has the code "D052". Wiley describes the entire process with screenshots in its instructions for gold [PDF].
• For a hybrid journal, you can select "Hybrid Open Access" when accepting your article. Confirm your Charité affiliation. Wiley describes the entire process with screenshots in its instructions for hybrid [PDF].

If you have any questions about the procedure, please do not hesitate to contact us.

Open Access